Maxitran 500 mg film-coated tablets No. 30
Other forms of release
- Tabletki.uaBuy
Registration number :MA No. UA/18255/01/01
Dosage form:Film-coated tablets
Active substance:tranexamic acid
Composition:1 tablet contains 500 mg of tranexamic acid; excipients: microcrystalline cellulose, low-substituted hydroxypropyl cellulose, povidone, colloidal anhydrous silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol 6000 (macrogol 6000), titanium dioxide (E 171), talc.
Therapeutic indications :
- use for short-term treatment of hyperfibrinolysis or fibrinogenolysis with haemorrhage or risk of haemorrhage;
- local fibrinolysis observed in the following conditions: - prostatectomy and interventions on the urinary bladder; - menorrhagia; - epistaxis; - conization of the cervix; - traumatic hyphema;
- congenital angioedema;
- tooth extraction in patients with haemophilia;
Shelf life :2 роки
Other in the therapeutic group